Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$23.75 - $31.69 $4,750 - $6,338
-200 Reduced 12.38%
1,416 $46,000
Q2 2021

Aug 05, 2021

BUY
$18.01 - $28.32 $7,654 - $12,036
425 Added 35.68%
1,616 $36,000
Q3 2020

Nov 04, 2020

SELL
$13.54 - $26.41 $2,708 - $5,282
-200 Reduced 14.38%
1,191 $20,000
Q1 2020

May 05, 2020

BUY
$5.57 - $11.5 $7,747 - $15,996
1,391 New
1,391 $12,000
Q4 2019

Feb 05, 2020

SELL
$7.9 - $10.14 $10,988 - $14,104
-1,391 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$15.51 - $17.61 $155 - $176
10 Added 0.72%
1,391 $25,000
Q4 2018

Jan 22, 2019

BUY
$14.52 - $19.72 $130 - $177
9 Added 0.66%
1,381 $23,000
Q3 2018

Oct 22, 2018

BUY
$14.85 - $16.35 $178 - $196
12 Added 0.88%
1,372 $21,000
Q2 2018

Jul 23, 2018

BUY
$13.8 - $16.8 $165 - $201
12 Added 0.89%
1,360 $21,000
Q1 2018

Apr 16, 2018

BUY
$13.8 - $16.2 $18,602 - $21,837
1,348 New
1,348 $20,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Horan Securities, Inc. Portfolio

Follow Horan Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Securities, Inc. with notifications on news.